• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化脓性汗腺炎与唐氏综合征:一项系统评价与荟萃分析。

Hidradenitis suppurativa and Down syndrome: A systematic review and meta-analysis.

作者信息

Lam Megan, Lai Charis, Almuhanna Nouf, Alhusayen Raed

机构信息

Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.

Faculty of Science, University of Western Ontario, London, ON, Canada.

出版信息

Pediatr Dermatol. 2020 Nov;37(6):1044-1050. doi: 10.1111/pde.14326. Epub 2020 Sep 6.

DOI:10.1111/pde.14326
PMID:32892406
Abstract

BACKGROUND

Hidradenitis suppurativa (HS), characterized by inflammatory nodules, sinus tracts, and abscesses, has been linked to several factors, including immune dysfunction and obesity, which are thought to contribute to its development. Several follicular disorders have also been associated with Down syndrome (DS), a common chromosomal disorder, including HS, although studies on this topic are limited.

OBJECTIVES

To characterize HS in Down syndrome patients and to further examine the association between HS and DS compared to HS patients without DS.

METHODS

We systematically searched MEDLINE, Embase, Web of Science, and CENTRAL electronic databases from their dates of conception to February 2020. Random-effects meta-analyses were performed analyzing (a) HS characteristics between DS and non-DS participants, and (b) prevalence or association between HS and DS compared to non-DS individuals.

RESULTS

Twelve studies were included in this systematic review, with a total of 358 participants presenting with both HS and DS. Pooled analysis of mean differences between DS and non-DS participants presenting with HS found a significantly younger age of HS symptom onset for DS patients (-6.24; 95% CI, -10.01--2.24). A meta-analysis examining the association between HS and DS found a significantly increased likelihood of HS in DS patients (OR 9.61; 95% CI, 5.70-16.20).

CONCLUSIONS

Our findings suggest an association between HS and DS, with DS patients suffering from an earlier onset of HS symptoms compared to non-DS patients.

摘要

背景

化脓性汗腺炎(HS)以炎性结节、窦道和脓肿为特征,与多种因素有关,包括免疫功能障碍和肥胖,这些因素被认为促使其发病。几种毛囊疾病也与常见的染色体疾病唐氏综合征(DS)有关,包括HS,不过关于这一主题的研究有限。

目的

描述唐氏综合征患者的HS特征,并与非唐氏综合征的HS患者相比,进一步研究HS与DS之间的关联。

方法

我们系统检索了MEDLINE、Embase、科学网和CENTRAL电子数据库,检索时间从其建库日期至2020年2月。进行随机效应荟萃分析,分析(a)唐氏综合征和非唐氏综合征参与者之间的HS特征,以及(b)与非唐氏综合征个体相比,HS与DS之间的患病率或关联性。

结果

本系统评价纳入了12项研究,共有358名同时患有HS和DS的参与者。对患有HS的唐氏综合征和非唐氏综合征参与者之间的平均差异进行汇总分析发现,唐氏综合征患者HS症状出现的年龄明显更小(-6.24;95%CI,-10.01--2.24)。一项检验HS与DS之间关联的荟萃分析发现,唐氏综合征患者患HS的可能性显著增加(OR 9.61;95%CI,5.70-16.20)。

结论

我们的研究结果表明HS与DS之间存在关联,与非唐氏综合征患者相比,唐氏综合征患者HS症状出现得更早。

相似文献

1
Hidradenitis suppurativa and Down syndrome: A systematic review and meta-analysis.化脓性汗腺炎与唐氏综合征:一项系统评价与荟萃分析。
Pediatr Dermatol. 2020 Nov;37(6):1044-1050. doi: 10.1111/pde.14326. Epub 2020 Sep 6.
2
Prevalence of hidradenitis suppurativa among patients with Down syndrome: a population-based cross-sectional analysis.患有唐氏综合征的患者中化脓性汗腺炎的患病率:基于人群的横断面分析。
Br J Dermatol. 2018 Mar;178(3):697-703. doi: 10.1111/bjd.15770. Epub 2018 Jan 17.
3
Hidradenitis Suppurativa Associated with Down Syndrome Is Characterized by Early Age at Diagnosis.患有唐氏综合征的化脓性汗腺炎的特点是诊断年龄较早。
Dermatology. 2018;234(1-2):66-70. doi: 10.1159/000487799. Epub 2018 Apr 24.
4
Hidradenitis suppurativa and chromosomal abnormalities: a case report and systematic review of the literature.化脓性汗腺炎与染色体异常:病例报告及文献系统回顾。
Int J Dermatol. 2021 Mar;60(3):261-271. doi: 10.1111/ijd.15111. Epub 2020 Aug 9.
5
Hidradenitis suppurativa and Down syndrome in a single-centre sample: A cross-sectional study.化脓性汗腺炎合并唐氏综合征的单中心样本:一项横断面研究。
Australas J Dermatol. 2022 Aug;63(3):e231-e237. doi: 10.1111/ajd.13872. Epub 2022 May 14.
6
Hidradenitis suppurativa (HS) and Down syndrome (DS): Increased prevalence and a younger age of hidradenitis symptom onset.化脓性汗腺炎(HS)与唐氏综合征(DS):化脓性汗腺炎患病率增加且症状出现年龄更小。
J Am Acad Dermatol. 2016 Sep;75(3):632-634. doi: 10.1016/j.jaad.2016.04.045.
7
Hidradenitis suppurativa in patients with Down syndrome.唐氏综合征患者的化脓性汗腺炎。
J Eur Acad Dermatol Venereol. 2019 Oct;33 Suppl 6:34-35. doi: 10.1111/jdv.15822.
8
The prevalence and odds of anxiety and depression in children and adults with hidradenitis suppurativa: Systematic review and meta-analysis.化脓性汗腺炎患儿和成年患者中焦虑和抑郁的患病率和比值比:系统评价和荟萃分析。
J Am Acad Dermatol. 2020 Aug;83(2):542-553. doi: 10.1016/j.jaad.2020.03.041. Epub 2020 Mar 25.
9
Risk of liver dysfunction and non-alcoholic fatty liver diseases in people with hidradenitis suppurativa: A systematic review and meta-analysis of real-world evidences.患有化脓性汗腺炎人群的肝功能障碍和非酒精性脂肪性肝病风险:真实世界证据的系统评价和荟萃分析。
Front Immunol. 2022 Dec 14;13:959691. doi: 10.3389/fimmu.2022.959691. eCollection 2022.
10
Association between Hidradenitis Suppurativa and Inflammatory Arthritis: A Systematic Review and Meta-Analysis.化脓性汗腺炎与炎症性关节炎的相关性:系统评价和荟萃分析。
Dermatology. 2021;237(5):740-747. doi: 10.1159/000514582. Epub 2021 Mar 26.

引用本文的文献

1
Management of Hidradenitis Suppurativa in Special Populations: A Narrative Review.特殊人群化脓性汗腺炎的管理:一项叙述性综述
Dermatol Ther (Heidelb). 2025 Jun 20. doi: 10.1007/s13555-025-01457-4.
2
Prevalence of Comorbidities Among Pediatric Patients With Hidradenitis Suppurativa: A Meta-Analysis.化脓性汗腺炎儿科患者合并症的患病率:一项荟萃分析。
JAMA Dermatol. 2025 Jun 11. doi: 10.1001/jamadermatol.2025.1565.
3
Characterizing Disease Severity, Comorbidities, and Treatment Plans in Pediatric Hidradenitis Suppurativa Patients With and Without Obesity: A Cohort and Cross-Sectional Analysis.
伴有和不伴有肥胖的儿童化脓性汗腺炎患者的疾病严重程度、合并症及治疗方案特征:一项队列研究和横断面分析
Pediatr Dermatol. 2025 Jul-Aug;42(4):773-778. doi: 10.1111/pde.15983. Epub 2025 May 15.
4
Safety and efficacy of biologics in patients with Down syndrome and hidradenitis suppurativa: a retrospective cohort study.生物制剂在唐氏综合征合并化脓性汗腺炎患者中的安全性和有效性:一项回顾性队列研究。
Clin Exp Dermatol. 2025 Jun 25;50(7):1431-1433. doi: 10.1093/ced/llaf090.
5
JAK inhibition decreases the autoimmune burden in Down syndrome.JAK抑制可减轻唐氏综合征中的自身免疫负担。
Elife. 2024 Dec 31;13:RP99323. doi: 10.7554/eLife.99323.
6
Common Dermatologic Disorders in Down Syndrome: Systematic Review.唐氏综合征常见皮肤疾病:系统评价
JMIR Dermatol. 2022 Feb 8;5(1):e33391. doi: 10.2196/33391.
7
JAK inhibition decreases the autoimmune burden in Down syndrome.JAK抑制可减轻唐氏综合征中的自身免疫负担。
medRxiv. 2024 Oct 16:2024.06.13.24308783. doi: 10.1101/2024.06.13.24308783.
8
Safety and Efficacy of Biologic Medications and Janus Kinase Inhibitors in Patients with Down Syndrome: A Retrospective Cohort Study.生物药物和Janus激酶抑制剂在唐氏综合征患者中的安全性和有效性:一项回顾性队列研究
Clin Drug Investig. 2024 Mar;44(3):219-222. doi: 10.1007/s40261-024-01348-0. Epub 2024 Feb 19.
9
[Epidemiology, patient quality of life, and treatment costs of hidradenitis suppurativa/acne inversa].[化脓性汗腺炎/反向性痤疮的流行病学、患者生活质量及治疗费用]
Hautarzt. 2021 Aug;72(8):651-657. doi: 10.1007/s00105-021-04851-z. Epub 2021 Jul 5.
10
Down syndrome and type I interferon: not so simple.唐氏综合征与 I 型干扰素:没那么简单。
Curr Opin Immunol. 2021 Oct;72:196-205. doi: 10.1016/j.coi.2021.06.006. Epub 2021 Jun 23.